Respiratory syncytial virus (RSV) suppression of glucocorticoid receptor phosphorylation does not account for repression of transactivation

被引:2
作者
Marketon, Jeanette I. Webster [1 ,2 ]
Corry, Jacqueline [1 ]
机构
[1] Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Dept Internal Med, Wexner Med Ctr, Columbus, OH 43210 USA
[2] Ohio State Univ, Wexner Med Ctr, Inst Behav Med Res, Columbus, OH 43210 USA
来源
FEBS OPEN BIO | 2013年 / 3卷
关键词
Respiratory syncytial virus; Glucocorticoid receptor; Transactivation; Phosphorylation; Protein phosphatase; DOUBLE-BLIND; CHILDREN; DEXAMETHASONE; INDUCTION; INFECTION; INFANTS; PP5;
D O I
10.1016/j.fob.2013.07.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Respiratory syncytial virus (RSV)-induced bronchiolitis in infants, although inflammatory in nature, is not responsive to glucocorticoids. We have recently shown that RSV-infected lung epithelial cells have impaired glucocorticoid receptor (GR)-mediated transactivation. In this study, we show that the N-terminal region of GR is required for RSV repression of GR transactivation and that RSV infection of lung epithelial cells reduces ligand-dependent GR phosphorylation at serine 211 and serine 226. However, we also show that these changes in GR phosphorylation do not account for the RSV repression of GR transactivation suggesting other regions of the GR N-terminus must also be involved. (C) 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical Societies. All rights reserved.
引用
收藏
页码:305 / 309
页数:5
相关论文
共 50 条
  • [41] Challenges in Maximizing Impacts of Preventive Strategies against Respiratory Syncytial Virus (RSV) Disease in Young Children
    Zheng, Zhe
    [J]. YALE JOURNAL OF BIOLOGY AND MEDICINE, 2022, 95 (02) : 293 - 300
  • [42] Influence of age, severity of infection, and co-infection on the duration of respiratory syncytial virus (RSV) shedding
    Munywoki, P. K.
    Koech, D. C.
    Agoti, C. N.
    Kibirige, N.
    Kipkoech, J.
    Cane, P. A.
    Medley, G. F.
    Nokes, D. J.
    [J]. EPIDEMIOLOGY AND INFECTION, 2015, 143 (04) : 804 - 812
  • [43] Household Transmission and Genomic Diversity of Respiratory Syncytial Virus (RSV) in the United States, 2022-2023
    Cox, Sarah N.
    Roychoudhury, Pavitra
    Frivold, Collrane
    Acker, Zack
    Babu, Tara M.
    Boisvert, Cassandra L.
    Carone, Marco
    Ehmen, Brenna
    Englund, Janet A.
    Feldstein, Leora R.
    Gamboa, Luis
    Grindstaff, Sally
    Grioni, Hanna M.
    Han, Peter D.
    Hoffman, Katherine L.
    Kim, Hyeong Geon
    Kuntz, Jennifer L.
    Lo, Natalie K.
    Lockwood, Christina M.
    Mccaffrey, Kathryn
    Mularski, Richard A.
    Hatchie, Tara L.
    Reich, Sacha L.
    Schmidt, Mark A.
    Smith, Ning
    Starita, Lea M.
    Varga, Alexandra
    Yetz, Neil
    Naleway, Allison L.
    Weil, Ana A.
    Chu, Helen Y.
    [J]. CLINICAL INFECTIOUS DISEASES, 2025,
  • [44] The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in Kenya
    Nyiro, Joyce U.
    Nyawanda, Bryan O.
    Mutunga, Martin
    Murunga, Nickson
    Nokes, D. James
    Bigogo, Godfrey
    Otieno, Nancy A.
    Lidechi, Shirley
    Mazoya, Bilali
    Jit, Mark
    Cohen, Cheryl
    Moyes, Jocelyn
    Pecenka, Clint
    Baral, Ranju
    Onyango, Clayton
    Munywoki, Patrick K.
    Vodicka, Elisabeth
    [J]. BMC PUBLIC HEALTH, 2024, 24 (01)
  • [45] Inhibition of respiratory syncytial virus replication and suppression of RSV-induced airway inflammation in neonatal rats by colchicine
    Lu, Nihong
    Yang, Yongrui
    Liu, Honglu
    Ding, Xiangli
    Ou, Yangbing
    Xia, Jiawei
    Du, Yingrong
    [J]. 3 BIOTECH, 2019, 9 (11)
  • [46] The Estimate of Parental Quality of Life Loss Due to Respiratory Syncytial Virus (RSV) Hospitalization
    Wrotek, August
    Wrotek, Oliwia
    Jackowska, Teresa
    [J]. DISEASES, 2023, 11 (04)
  • [47] Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand
    Prasad, Namrata
    Read, M. Jonathan
    Jewell, Christopher
    Waite, Ben
    Trenholme, A. Adrian
    Huang, Q. Sue
    Grant, C. Cameron
    Newbern, E. Claire
    Hogan, B. Alexandra
    [J]. VACCINE, 2021, 39 (31) : 4383 - 4390
  • [48] Titanium dioxide nanoparticles exacerbate pneumonia in respiratory syncytial virus (RSV)-infected mice
    Hashiguchi, Seiko
    Yoshida, Hiroki
    Akashi, Toshi
    Komemoto, Keiji
    Ueda, Tomoyuki
    Ikarashi, Yoshiaki
    Miyauchi, Aki
    Konno, Katsuhiko
    Yamanaka, Sayoko
    Hirose, Akihiko
    Kurokawa, Masahiko
    Watanabe, Wataru
    [J]. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2015, 39 (02) : 879 - 886
  • [49] Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
    Mejias, Asuncion
    Ramilo, Octavio
    [J]. BIOLOGICS-TARGETS & THERAPY, 2008, 2 (03) : 433 - 439
  • [50] Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections
    Rodriguez, WJ
    Gruber, WC
    Welliver, RC
    Groothuis, JR
    Simoes, EAF
    Meissner, HC
    Hemming, VG
    Hall, CB
    Lepow, ML
    Rosas, AJ
    Robertsen, C
    Kramer, AA
    Kim, HW
    Arrobio, J
    Milburn, C
    Baker, J
    Satterwhite, P
    Steel, L
    Bender, P
    King, S
    Levin, M
    Aronoff, S
    Baer, L
    Sanchez, J
    Top, FH
    Hensen, SA
    Peterson, MB
    [J]. PEDIATRICS, 1997, 99 (03) : 454 - 461